These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9382953)

  • 1. Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy.
    Murphy JE; Rheinwald JG
    Hum Gene Ther; 1997 Nov; 8(16):1867-79. PubMed ID: 9382953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesothelial cells: the panacea for ex vivo gene therapy?
    Paillard F
    Hum Gene Ther; 1997 Nov; 8(16):1839-40. PubMed ID: 9382949
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells.
    Hurwitz DR; Kirchgesser M; Merrill W; Galanopoulos T; McGrath CA; Emami S; Hansen M; Cherington V; Appel JM; Bizinkauskas CB; Brackmann HH; Levine PH; Greenberger JS
    Hum Gene Ther; 1997 Jan; 8(2):137-56. PubMed ID: 9017418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C; Bergeron C; Lane D; Garon G; Piché A
    Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface.
    Nagy JA; Shockley TR; Masse EM; Harvey VS; Hoff CM; Jackman RW
    Gene Ther; 1995 Aug; 2(6):402-10. PubMed ID: 7584115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of anemia in uremic mice by genetically modified peritoneal mesothelial cells.
    Einbinder T; Sufaro Y; Yusim I; Byk G; Passlick-Deetjen J; Chaimovitz C; Douvdevani A
    Kidney Int; 2003 Jun; 63(6):2103-12. PubMed ID: 12753297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo expression of human growth hormone by genetically modified murine bone marrow stromal cells and its effect on the cells in vitro.
    Suzuki K; Oyama M; Faulcon L; Robbins PD; Niyibizi C
    Cell Transplant; 2000; 9(3):319-27. PubMed ID: 10972331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelial cell-mediated gene therapy: feasibility of an ex vivo strategy.
    Nagy JA; Shockley TR; Masse EM; Harvey VS; Jackman RW
    Gene Ther; 1995 Aug; 2(6):393-401. PubMed ID: 7584114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation.
    Setoguchi Y; Jaffe HA; Chu CS; Crystal RG
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):369-77. PubMed ID: 8136153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
    Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
    Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors.
    Ayuso E; Chillón M; Agudo J; Haurigot V; Bosch A; Carretero A; Otaegui PJ; Bosch F
    Hum Gene Ther; 2004 Aug; 15(8):805-12. PubMed ID: 15319037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
    Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
    Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of transgene expression in mesothelial cells by activation of an inducible promoter.
    Hoff CM; Cusick JL; Masse EM; Jackman RW; Nagy JA; Shockley TR
    Nephrol Dial Transplant; 1998 Jun; 13(6):1420-9. PubMed ID: 9641171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral-mediated gene transfer into primary human and mouse mammary epithelial cells in vitro and in vivo.
    Yang J; Tsukamoto T; Popnikolov N; Guzman RC; Chen X; Yang JH; Nandi S
    Cancer Lett; 1995 Nov; 98(1):9-17. PubMed ID: 8529212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases in weight of growth hormone-deficient and immunodeficient (lit/scid) dwarf mice after grafting of hGH-secreting, primary human keratinocytes.
    Bellini MH; Peroni CN; Bartolini P
    FASEB J; 2003 Dec; 17(15):2322-4. PubMed ID: 14525947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK; Armentano D; Wands JR; Mohr L
    Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-guided percutaneous delivery of adenoviral vectors encoding the beta-galactosidase and human factor IX genes to early gestation fetal sheep in utero.
    David A; Cook T; Waddington S; Peebles D; Nivsarkar M; Knapton H; Miah M; Dahse T; Noakes D; Schneider H; Rodeck C; Coutelle C; Themis M
    Hum Gene Ther; 2003 Mar; 14(4):353-64. PubMed ID: 12659676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin control of exocrine protein levels in saliva after adenoviral vector-mediated gene transfer.
    Wang J; Voutetakis A; Zheng C; Baum BJ
    Gene Ther; 2004 Apr; 11(8):729-33. PubMed ID: 14737095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenovirus administration in rat peritoneum: endothelial expression and safety concerns.
    Martin-Martinez MD; Stoenoiu M; Verkaeren C; Devuyst O; Delporte C
    Nephrol Dial Transplant; 2004 May; 19(5):1293-7. PubMed ID: 14993505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity.
    Tanaka F; Tominaga K; Shiota M; Ochi M; Kuwamura H; Tanigawa T; Watanabe T; Fujiwara Y; Oshitani N; Higuchi K; Iwao H; Arakawa T
    Cancer Gene Ther; 2008 Jan; 15(1):51-9. PubMed ID: 17992202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.